The treatment of hepatocellular carcinoma with N-acetylcysteine (NAC) has been shown to impede GLUD1 activation and mitochondrial apoptosis via the ROS-mediated p38/JNK MAPK pathway [48]. This evidence concerns the gene GLUD1 and hepatocellular carcinoma.